CASI Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2021
Total Assets: $138.3M
Liabilities Breakdown FY2021
Total Liabilities: $30.3M
Asset Breakdown
Total Assets: $138.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $38.7M | 28.0% |
| Accounts Receivable | $9.8M | 7.1% |
| Inventory | $1.9M | 1.4% |
| Property, Plant & Equipment | $12.7M | 9.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $12.2M | 8.8% |
| Other Assets | $63.0M | 45.5% |
Liabilities Breakdown
Total Liabilities: $30.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.2M | 7.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $28.1M | 92.7% |